HYBRID EVENT: Join us in person in Tokyo, Japan or attend virtually from anywhere.
Targeted oncology represents a revolutionary approach in cancer treatment that focuses on identifying and attacking specific molecules or pathways involved in the growth and survival of cancer cells. Unlike traditional chemotherapy, which can affect both cancerous and healthy cells, targeted therapies aim to selectively target the abnormalities unique to cancer cells, minimizing damage to normal tissues. This precision medicine approach has opened new avenues for more effective and less toxic cancer treatments.
Targeted therapies employ various mechanisms to disrupt specific molecular processes that contribute to cancer progression. This can include blocking the signals that promote uncontrolled cell growth, inhibiting blood vessel formation within tumors (angiogenesis), or triggering programmed cell death (apoptosis). These therapies often involve the use of small molecules or monoclonal antibodies designed to interfere with the targeted molecules or pathways. The selection of targeted therapies is guided by the specific genetic and molecular characteristics of an individual's cancer, making it a highly personalized and tailored approach to treatment.
